Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53

Benzinga Newsdesk www.benzinga.com Positive 56.7%

Neg 0% Neu 0% Pos 56.7%

Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $50 to $53.